Showing results (171-180 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|October 27, 2004
Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphismA K Tiwari, S N Deshpande, A R Rao, et al.
The Pharmacogenomics Journal|October 27, 2004
Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patientsJ Redon, M Luque-Otero, N Martell, et al.
The Pharmacogenomics Journal|April 13, 2005
Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance doseD Herman, I Locatelli, I Grabnar, et al.
The Pharmacogenomics Journal|August 19, 2007
The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancerO Capitain, M Boisdron-Celle, A-L Poirier, et al.
The Pharmacogenomics Journal|August 9, 2007
Pharmacogenetic studies in depression: a proposal for methodologic guidelinesA Serretti, M Kato, J L Kennedy
The Pharmacogenomics Journal|August 9, 2007
Genetic polymorphisms of NAD(P)H oxidase: variation in subunit expression and enzyme activityM Schirmer, M Hoffmann, E Kaya, et al.
The Pharmacogenomics Journal|August 9, 2007
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in miceM A Steiner, K Wanisch, K Monory, et al.
The Pharmacogenomics Journal|January 4, 2007
Nucleotide sequence variation within the human tyrosine kinase B neurotrophin receptor gene: association with antisocial alcohol dependenceK Xu, T R Anderson, K M Neyer, et al.
The Pharmacogenomics Journal|February 28, 2007
Apolipoprotein E genotype and warfarin dosing among Caucasians and African AmericansS E Kimmel, J Christie, C Kealey, et al.
The Pharmacogenomics Journal|February 28, 2007
The concentration-dependent effects of ethanol on Caenorhabditis elegans behaviourP H Mitchell, K Bull, S Glautier, et al.
Pageof 135